Joint Formulary & PAD

Levocarnitine - Carnitine deficiency

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Intravenous injection (IV)
Associated Icons :
NFD1
NHSE
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Levocarnitine
Indication :
Carnitine deficiency in haemodialysis
Group Name :
Keywords :
Haemodialysis, L-carnitine, metabolic disorders
Brand Names Include :
Important Information :

NHSE specialised commissioned services only. Not commissioned from any acute Trust in Surrey Heartlands.
L-carnitine / levocarnitine in valproate toxicity has a separate formulary entry.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Levocarnitine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Carnitine deficiency in haemodialysis.

  • No records returned.